3,6-Dichloropyridazine
141-30-0Clc1ccc(Cl)nn1GUSWJGOYDXFJSI-UHFFFAOYSA-N141-30-0DTXSID4059704Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H301 (81%): Toxic if swallowed [Danger Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 58 reports by companies from 12 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Warning
H373: May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]
Causes somnolence, ataxia, and weight loss in inhalation lethal-concentration studies of rats; Causes somnolence and muscle weakness in oral lethal-dose studies of rats; [RTECS] A skin and strong eye irritant; Toxic by ingestion; [Sigma-Aldrich MSDS] See Maleic hydrazide and Pyrazon.
Acute Tox. 3 (81%)
Specific target organ toxicity - Repeated exposure - Category 2 (liver, kidney, testis)
Verwenden3,6-Dichloropyridazine is used as an intermediate in synthetic chemistry, especially in active pharmaceutical ingredients. It is used in the preparation of alfa-(halohetaroyl)-2-azahetarylacetonitriles.
Wird geladen…